Back to News
Market Impact: 0.55

These stocks reporting earnings next have a history of beating expectations

GOOGLGOOGTSLAGMCMGDBISRGPIPR
Corporate EarningsAnalyst EstimatesAnalyst InsightsCorporate Guidance & OutlookCompany FundamentalsHealthcare & BiotechTechnology & InnovationPrivate Markets & Venture
These stocks reporting earnings next have a history of beating expectations

As the Q2 earnings season ramps up with nearly 100 S&P 500 companies reporting next week, a data screen identifies Chipotle Mexican Grill (CMG) and Intuitive Surgical (ISRG) as stocks with a strong historical tendency to beat earnings estimates and rally afterward. Chipotle, reporting next Wednesday, has topped EPS estimates 78% of the time with an average 1.6% post-earnings gain, prompting Deutsche Bank to reiterate a Buy rating with 31% potential upside. Intuitive Surgical, also reporting next week, has beaten bottom-line estimates 88% of the time, averaging a 2.5% gain, benefiting from growing optimism around its new Da Vinci 5 robotic surgery system.

Analysis

With 98 S&P 500 firms reporting next week, data from Bespoke Investor Group highlights Chipotle Mexican Grill (CMG) and Intuitive Surgical (ISRG) as companies with a strong historical pattern of exceeding earnings estimates and seeing subsequent stock price increases. Chipotle has surpassed earnings per share estimates in 78% of its reports, leading to an average next-day gain of 1.6%. Despite an 11% year-to-date decline in its share price, Deutsche Bank has reiterated a buy rating, viewing the second quarter as a fundamental trough with accelerating trends expected to support H2 estimates and offering a potential 31% upside to its $70 price target. Intuitive Surgical presents an even stronger historical record, beating bottom-line estimates 88% of the time and averaging a 2.5% stock gain on earnings day. Investor optimism, reflected in a 7% share price increase over the last three months, is tied to the new Da Vinci 5 robotic surgery system. Furthermore, Piper Sandler suggests that the company's total addressable market could also expand significantly through its Ion endoluminal robot and venture capital portfolio, indicating multiple avenues for future growth.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.